Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mitomycin"" wg kryterium: Temat


Tytuł :
Re: Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-Muscle-Invasive Bladder Cancer.
Autorzy :
Chang SS
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 1095. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Administration, Intravesical ; Antibiotics, Antineoplastic/therapeutic use ; Humans
Czasopismo naukowe
Tytuł :
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer.
Autorzy :
Mostafid AH; Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
Porta N; Institute of Cancer Research, London, UK.
Cresswell J; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
Griffiths TRL; University Hospitals of Leicester NHS Trust, Leicester, UK.
Kelly JD; University College London, London, UK.
Penegar SR; Institute of Cancer Research, London, UK.
Davenport K; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
McGrath JS; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Campain N; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Cooke P; Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
Masood S; Medway NHS Foundation Trust, Gillingham, UK.
Knowles MA; University of Leeds, Leeds, UK.
Feber A; University College London, London, UK.
Knight A; Action Bladder Cancer UK, Gloucestershire, UK.
Catto JWF; University of Sheffield, Sheffield, UK.
Lewis R; Institute of Cancer Research, London, UK.
Hall E; Institute of Cancer Research, London, UK.
Pokaż więcej
Źródło :
BJU international [BJU Int] 2020 Jun; Vol. 125 (6), pp. 817-826. Date of Electronic Publication: 2020 Apr 03.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibiotics, Antineoplastic*/administration & dosage
Antibiotics, Antineoplastic*/therapeutic use
Mitomycin*/administration & dosage
Mitomycin*/therapeutic use
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/surgery
Administration, Intravesical ; Aged ; Aged, 80 and over ; Feasibility Studies ; Female ; Humans ; Male ; Middle Aged ; Quality of Life
Czasopismo naukowe
Tytuł :
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Autorzy :
Kleinmann N; Department of Urology, Sheba Medical Center, Ramat Gan, Israel.
Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pierorazio PM; Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Gore JL; Department of Urology, University of Washington Medical Center, Seattle, WA, USA.
Shabsigh A; Department of Urology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Hu B; Department of Urology, Loma Linda University, Loma Linda, CA, USA.
Chamie K; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA.
Godoy G; Department of Urology, Baylor College of Medicine, Houston, TX, USA.
Hubosky S; Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University Hospitals, Philadelphia, PA, USA.
Rivera M; Department of Urology, Mayo Clinic Health System, Rochester, MN, USA.
O'Donnell M; Department of Urology, University of Iowa, Iowa City, IA, USA.
Quek M; Department of Urology, Loyola University Medical Center, Maywood, IL, USA.
Raman JD; Division of Urology, Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA.
Knoedler JJ; Division of Urology, Penn State Health Milton S Hershey Medical Center, Hershey, PA, USA.
Scherr D; Department of Urology, Weill Medical College of Cornell University, New York, NY, USA.
Stern J; Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA.
Weight C; Department of Urology, University of Minnesota Health, Minneapolis, MN, USA.
Weizer A; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
Woods M; Department of Urology, Loyola University Medical Center, Maywood, IL, USA.
Kaimakliotis H; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Smith AB; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Linehan J; Department of Urology, John Wayne Cancer Institute, Santa Monica, CA, USA.
Coleman J; Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Humphreys MR; Department of Urology, Mayo Clinic Phoenix, Scottsdale, AZ, USA.
Pak R; Department of Urology, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
Lifshitz D; Department of Urology, Rabin Medical Center, Tel Aviv, Israel.
Verni M; Urology Center of Las Vegas, Las Vegas, NV, USA.
Adibi M; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Amin MB; Department of Pathology, University of Tennessee Health Science Center, Memphis, TN, USA.
Seltzer E; UroGen Pharma, New York, NY, USA.
Klein I; UroGen Pharma, Ra'anana, Israel.
Konorty M; UroGen Pharma, Ra'anana, Israel.
Strauss-Ayali D; UroGen Pharma, Ra'anana, Israel.
Hakim G; UroGen Pharma, Ra'anana, Israel.
Schoenberg M; Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA; UroGen Pharma, New York, NY, USA.
Lerner SP; Department of Urology, Baylor College of Medicine, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Jun; Vol. 21 (6), pp. 776-785. Date of Electronic Publication: 2020 Apr 29.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Carriers*
Antibiotics, Antineoplastic/*administration & dosage
Carcinoma/*drug therapy
Kidney Neoplasms/*drug therapy
Mitomycin/*administration & dosage
Urothelium/*drug effects
Adult ; Aged ; Aged, 80 and over ; Antibiotics, Antineoplastic/adverse effects ; Carcinoma/pathology ; Drug Compounding ; Female ; Humans ; Hydrogels ; Israel ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Mitomycin/adverse effects ; Neoplasm Grading ; Time Factors ; Treatment Outcome ; United States ; Urothelium/pathology
Czasopismo naukowe
Tytuł :
Successful use of topical mitomycin C for the treatment of a putative neoplastic vascular mass on the nictitating membrane of a dog.
Autorzy :
Seavers A; Oak Flats Veterinary Clinic, Oak Flats, New South Wales, 2529, Australia.
Robson D; Dermatology Department, Melbourne Veterinary Specialist Centre, Glen Waverly, Victoria, 3150, Australia.
Weingarth JM; Oak Flats Veterinary Clinic, Oak Flats, New South Wales, 2529, Australia.
Pokaż więcej
Źródło :
Australian veterinary journal [Aust Vet J] 2020 Apr; Vol. 98 (4), pp. 164-167. Date of Electronic Publication: 2020 Jan 09.
Typ publikacji :
Case Reports
MeSH Terms :
Mitomycin*
Nictitating Membrane*
Dog Diseases/*drug therapy
Administration, Topical ; Animals ; Antibiotics, Antineoplastic/therapeutic use ; Dogs ; Female ; Neoplasms/drug therapy ; Neoplasms/veterinary
Raport
Tytuł :
Historical Considerations and Innovations in the Perioperative Use of Mitomycin C for Glaucoma Filtration Surgery and Bleb Revisions.
Autorzy :
Grover DS; Glaucoma Associates of Texas, Dallas, TX.
Kornmann HL
Fellman RL
Pokaż więcej
Źródło :
Journal of glaucoma [J Glaucoma] 2020 Mar; Vol. 29 (3), pp. 226-235.
Typ publikacji :
Historical Article; Journal Article; Review
MeSH Terms :
Alkylating Agents/*history
Filtering Surgery/*history
Glaucoma/*history
Mitomycin/*history
Alkylating Agents/administration & dosage ; Female ; Glaucoma/surgery ; History, 20th Century ; History, 21st Century ; Humans ; Intraocular Pressure ; Male ; Mitomycin/administration & dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Controlled release of Mitomycin C from modified cellulose based thermo-gel prevents post-operative de novo peritoneal adhesion.
Autorzy :
Sultana T; Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan,31151, Republic of Korea.
Van Hai H; Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan,31151, Republic of Korea.
Park M; Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan,31151, Republic of Korea.
Lee SY; Division of Environmental Material Engineering, Department of Forest Products, Korea Forest Research Institute, Seoul, Republic of Korea.
Lee BT; Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan,31151, Republic of Korea; Institute of Tissue Regeneration, Soonchunhyang University, Cheonan, 31151, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Carbohydrate polymers [Carbohydr Polym] 2020 Feb 01; Vol. 229, pp. 115552. Date of Electronic Publication: 2019 Nov 02.
Typ publikacji :
Journal Article
MeSH Terms :
Cellulose/*chemistry
Hydrogels/*chemistry
Mitomycin/*chemistry
Peritoneum/*pathology
Tissue Adhesions/*prevention & control
Animals ; Cell Adhesion/drug effects ; Cell Line ; Cell Survival/drug effects ; Compressive Strength ; Drug Carriers/chemistry ; Drug Liberation ; Hydrogels/pharmacology ; Hydrogels/therapeutic use ; Mice ; Mitomycin/metabolism ; Mitomycin/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Rheology ; Temperature ; Viscosity
Czasopismo naukowe
Tytuł :
Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study.
Autorzy :
Ba M; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China. .
Cui S; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China. .
Long H; Department of Pharmacy, Guangzhou Dermatology Institute, Guangzhou, Guangdong, People's Republic of China.
Gong Y; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China.
Wu Y; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China.
Lin K; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China.
Tu Y; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China.
Zhang B; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China.
Wu W; Intracelom Hyperthermic Perfusion Therapy Center, Cancer Hospital of Guangzhou Medical University, No. 78 Hengzhigang Road, Guangzhou, Guangdong, 510095, People's Republic of China.
Pokaż więcej
Źródło :
BMC urology [BMC Urol] 2019 Dec 03; Vol. 19 (1), pp. 126. Date of Electronic Publication: 2019 Dec 03.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Antibiotics, Antineoplastic/*therapeutic use
Hyperthermia, Induced/*instrumentation
Mitomycin/*therapeutic use
Urinary Bladder Neoplasms/*drug therapy
Adult ; Aged ; Analysis of Variance ; Animals ; Antibiotics, Antineoplastic/blood ; Antibiotics, Antineoplastic/pharmacokinetics ; Cystoscopy/methods ; Disease-Free Survival ; Equipment Design ; Feasibility Studies ; Female ; Hot Temperature/therapeutic use ; Humans ; Hyperthermia, Induced/adverse effects ; Hyperthermia, Induced/methods ; Male ; Middle Aged ; Mitomycin/blood ; Mitomycin/pharmacokinetics ; Neoplasm Recurrence, Local ; Random Allocation ; Swine ; Time Factors ; Urinary Bladder Neoplasms/metabolism ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.
Autorzy :
Schmidt S; für Urologie, Martin-Buber-Str. 10, Berlin, Germany, 14163.
Kunath F; für Urologie, Martin-Buber-Str. 10, Berlin, Germany, 14163.; University Hospital Erlangen, Department of Urology, Krankenhausstrasse 12, Erlangen, Germany, 91054.
Coles B; Cardiff University Library Services, Velindre NHS Trust, Velindre Cancer Centre, Whitchurch, Cardiff, UK, CF14 2TL.
Draeger DL; für Urologie, Martin-Buber-Str. 10, Berlin, Germany, 14163.; University of Rostock, Department of Urology, Ernst-Heydemann-Strasse 7, Rostock, Mecklenburg-Vorpommern, Germany, 18057.
Krabbe LM; für Urologie, Martin-Buber-Str. 10, Berlin, Germany, 14163.; University of Muenster Medical Center, Department of Urology, Albert-Schweitzer Campus 1, GB A1, Muenster, NRW, Germany, 48149.
Dersch R; Medical Center - University of Freiburg, Department of Neurology and Neurophysiology, Berliner Allee 29, Freiburg, Germany, 79110.
Kilian S; University of Heidelberg, Institute of Medical Biometry and Informatics, Heidelberg, Germany.
Jensen K; University of Heidelberg, Institute of Medical Biometry and Informatics, Heidelberg, Germany.
Dahm P; Minneapolis VA Health Care System, Urology Section, One Veterans Drive, Mail Code 112D, Minneapolis, Minnesota, USA, 55417.; University of Minnesota, Department of Urology, 420 Delaware Street SE, MMC 394, Minneapolis, Minnesota, USA, 55455.
Meerpohl JJ; Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Institute for Evidence in Medicine, Breisacher Str. 153, Freiburg, Germany, D-79110.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Jan 08; Vol. 1. Cochrane AN: CD011935. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Antibiotics, Antineoplastic/*therapeutic use
Carcinoma, Transitional Cell/*drug therapy
Mitomycin/*therapeutic use
Urinary Bladder Neoplasms/*drug therapy
Administration, Intravesical ; Antibiotics, Antineoplastic/administration & dosage ; BCG Vaccine ; Humans ; Mitomycin/administration & dosage ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Effect of Mitomycin C on Reducing Endometrial Fibrosis for Intrauterine Adhesion.
Autorzy :
Xu F; Department of Obstetrics and Gynecology, Wenzhou People's Hospital, Wenzhou, Zhejiang, China (mainland).
Shen X; Department of Obstetrics and Gynecology, Wenzhou People's Hospital, Wenzhou, Zhejiang, China (mainland).
Sun C; Laboratory of Obstetric, Wenzhou People's Hospital, Wenzhou, Zhejiang, China (mainland).
Xu X; Laboratory of Obstetric, Wenzhou People's Hospital, Wenzhou, Zhejiang, China (mainland).
Wang W; Laboratory of Obstetric, Wenzhou People's Hospital, Wenzhou, Zhejiang, China (mainland).
Zheng J; Laboratory of Obstetric, Wenzhou People's Hospital, Wenzhou, Zhejiang, China (mainland).
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2020 Jan 02; Vol. 26, pp. e920670. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
MeSH Terms :
Endometrium/*pathology
Mitomycin/*therapeutic use
Tissue Adhesions/*drug therapy
Uterus/*pathology
Animals ; Apoptosis/drug effects ; Cell Cycle Checkpoints/drug effects ; Cell Survival/drug effects ; Collagen Type I/metabolism ; Disease Models, Animal ; Estradiol/pharmacology ; Female ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Fibrosis ; Mitomycin/pharmacology ; Rats, Sprague-Dawley ; Stromal Cells/drug effects ; Stromal Cells/metabolism
Czasopismo naukowe
Tytuł :
[Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients].
Autorzy :
Marquette T; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Walz J; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Rybikowski S; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Maubon T; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Branger N; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Fakhfakh S; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Verde KL; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France.
Dermeche S; Service d'Oncologie Médicale, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite, 13009 Marseille, France.
Gravis G; Service d'Oncologie Médicale, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite, 13009 Marseille, France.
Pignot G; Service de Chirurgie Oncologique 2, Institut Paoli-Calmettes, 232, boulevard de Sainte Marguerite 13009 Marseille, France. Electronic address: .
Pokaż więcej
Transliterated Title :
Tolérance de la thermo-chimiothérapie par HIVEC® chez les patients réfractaires au BCG.
Źródło :
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie [Prog Urol] 2020 Jan; Vol. 30 (1), pp. 35-40. Date of Electronic Publication: 2019 Nov 28.
Typ publikacji :
Journal Article
MeSH Terms :
Antibiotics, Antineoplastic/*administration & dosage
BCG Vaccine/*administration & dosage
Mitomycin/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Administration, Intravesical ; Adult ; Aged ; Aged, 80 and over ; Antibiotics, Antineoplastic/adverse effects ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Hyperthermia, Induced ; Male ; Middle Aged ; Mitomycin/adverse effects ; Prospective Studies ; Surveys and Questionnaires ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer.
Autorzy :
Yamamoto S; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan .
Kageyama Y; Department of Urology, Saitama Cancer Center, Saitama, Japan.
Fujii Y; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Aizawa T; Department of Urology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
Urakami S; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Fukui I; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Sep; Vol. 40 (9), pp. 5295-5299.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Postoperative Care*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Urinary Bladder Neoplasms/*drug therapy
Administration, Intravesical ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Combined Modality Therapy ; Cystoscopes ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Female ; Humans ; Male ; Middle Aged ; Mitomycin/administration & dosage ; Neoplasm Grading ; Neoplasm Staging ; Recurrence ; Treatment Outcome ; Tumor Burden ; Urinary Bladder Neoplasms/diagnosis
Czasopismo naukowe
Tytuł :
Efficacy and Safety of the Local Application of Mitomycin C to Recurrent Esophageal Strictures in Children.
Autorzy :
Ley D; National Reference Centre for Congenital Malformation of the Oesophagus University Lille, Inserm, CHU Lille, Lille.
Bridenne M; National Reference Centre for Congenital Malformation of the Oesophagus University Lille, Inserm, CHU Lille, Lille.
Gottrand F; National Reference Centre for Congenital Malformation of the Oesophagus University Lille, Inserm, CHU Lille, Lille.
Lemale J; Department of Pediatrics, Trousseau University Hospital, Paris, France.
Hauser B; Department of Pediatrics, University Hospital, Brusselles, Belgium.
Lachaux A; Department of Pediatrics, University Hospital, Lyon.
Rebouissoux L; Department of Pediatrics, University Hospital, Bordeaux.
Viala J; Department of Pediatrics, Robert Debré University Hospital, Paris, France.
Fayoux P; National Reference Centre for Congenital Malformation of the Oesophagus University Lille, Inserm, CHU Lille, Lille.
Michaud L; National Reference Centre for Congenital Malformation of the Oesophagus University Lille, Inserm, CHU Lille, Lille.
Pokaż więcej
Źródło :
Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2019 Nov; Vol. 69 (5), pp. 528-532.
Typ publikacji :
Journal Article
MeSH Terms :
Antibiotics, Antineoplastic/*therapeutic use
Esophageal Stenosis/*drug therapy
Mitomycin/*therapeutic use
Administration, Mucosal ; Adolescent ; Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/adverse effects ; Child ; Child, Preschool ; Esophagoscopy ; Female ; Humans ; Infant ; Male ; Mitomycin/administration & dosage ; Mitomycin/adverse effects ; Postoperative Complications ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Synthesis of Mitomycin C and decarbamoylmitomycin C N deoxyadenosine-adducts.
Autorzy :
Zheng M; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: .
Hwang S; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: .
Snyder T; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: .
Aquilina J; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: .
Proni G; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: .
Paz MM; Departamento de Química Orgánica, Facultade de Química, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. Electronic address: .
Pradhan P; The City College, 138th Street at Convent Avenue, New York, NY 10031, USA. Electronic address: .
Cheng SY; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA. Electronic address: .
Champeil E; John Jay College of Criminal Justice, New York, 524 West 59(th) Street, New York, NY 10019, USA; The Graduate Center of the City University of New York, New York, NY 10016, USA. Electronic address: .
Pokaż więcej
Źródło :
Bioorganic chemistry [Bioorg Chem] 2019 Nov; Vol. 92, pp. 103280. Date of Electronic Publication: 2019 Sep 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Deoxyadenosines/*chemical synthesis
Mitomycin/*chemical synthesis
Mitomycins/*chemical synthesis
Alkylation ; DNA Adducts/analysis ; DNA Adducts/metabolism ; Deoxyadenosines/chemistry ; Fungal Proteins/metabolism ; Mitomycin/chemistry ; Mitomycins/chemistry ; Molecular Conformation ; Single-Strand Specific DNA and RNA Endonucleases/metabolism ; Stereoisomerism
Czasopismo naukowe
Tytuł :
The Use of TAT Peptide-Functionalized Graphene as a Highly Nuclear-Targeting Carrier System for Suppression of Choroidal Melanoma.
Autorzy :
Shan S; Laboratory of Nanoscale Biosensing and Bioimaging, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, 270 Xueyuanxi Road, Wenzhou 325027, China. .
Jia S; Laboratory of Nanoscale Biosensing and Bioimaging, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, 270 Xueyuanxi Road, Wenzhou 325027, China. .
Lawson T; ARC Center of Excellence for Nanoscale Bio Photonics, Macquarie University, Sydney, NSW 2109, Australia. .
Yan L; Laboratory of Nanoscale Biosensing and Bioimaging, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, 270 Xueyuanxi Road, Wenzhou 325027, China. .
Lin M; Laboratory of Nanoscale Biosensing and Bioimaging, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, 270 Xueyuanxi Road, Wenzhou 325027, China. .
Liu Y; Laboratory of Nanoscale Biosensing and Bioimaging, School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, 270 Xueyuanxi Road, Wenzhou 325027, China. .
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2019 Sep 10; Vol. 20 (18). Date of Electronic Publication: 2019 Sep 10.
Typ publikacji :
Journal Article
MeSH Terms :
Choroid Neoplasms/*drug therapy
Drug Delivery Systems/*methods
Graphite/*chemistry
Melanoma/*drug therapy
Mitomycin/*administration & dosage
Peptides/*chemistry
Antibiotics, Antineoplastic/administration & dosage ; Antibiotics, Antineoplastic/chemistry ; Cell Line ; Cell Line, Tumor ; Cell Nucleus/drug effects ; Cell Nucleus/metabolism ; Cell Nucleus/ultrastructure ; Choroid Neoplasms/metabolism ; Choroid Neoplasms/pathology ; Drug Carriers/chemistry ; Humans ; Melanoma/metabolism ; Melanoma/pathology ; Microscopy, Electron, Transmission ; Mitomycin/chemistry ; Nanostructures/administration & dosage ; Nanostructures/chemistry ; Nanostructures/ultrastructure ; tat Gene Products, Human Immunodeficiency Virus/chemistry
Czasopismo naukowe
Tytuł :
FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links.
Autorzy :
Awate S; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Sommers JA; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Datta A; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Nayak S; Department of Cancer Biology, University of Massachusetts Medical School - UMASS Memorial Cancer Center, Worcester, MA, USA.
Bellani MA; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Yang O; Department of Biophysics and Biophysical Chemistry, Johns Hopkins University, Baltimore, MD, USA.
Dunn CA; Flow Cytometry Unit, National Institute on Aging, NIH, Baltimore, MD, USA.
Nicolae CM; Department of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA, USA.
Moldovan GL; Department of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA, USA.
Seidman MM; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Cantor SB; Department of Cancer Biology, University of Massachusetts Medical School - UMASS Memorial Cancer Center, Worcester, MA, USA.
Brosh RM; Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Sep 18; Vol. 48 (16), pp. 9161-9180.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
BRCA1 Protein/*genetics
DNA-Binding Proteins/*genetics
Fanconi Anemia Complementation Group Proteins/*genetics
Genomic Instability/*genetics
Histone Chaperones/*genetics
RNA Helicases/*genetics
Rad51 Recombinase/*genetics
Chromosomal Instability/genetics ; DNA Breaks, Double-Stranded/drug effects ; DNA Damage/genetics ; DNA Repair/genetics ; DNA-Binding Proteins/deficiency ; Gene Knockout Techniques ; HeLa Cells ; Histone Chaperones/deficiency ; Humans ; Mitomycin/pharmacology ; Recombinational DNA Repair/genetics
Czasopismo naukowe
Tytuł :
[Diagnosis and Therapy of Benign and Malignant Tumors of the Conjunctiva].
Autorzy :
Westekemper H
Manthey A
Bechrakis N
Pokaż więcej
Transliterated Title :
Benigne und maligne Bindehauttumoren in Diagnostik und Therapie.
Źródło :
Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2020 Sep; Vol. 237 (9), pp. 1143-1159. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Melanoma*
Conjunctival Neoplasms/*diagnosis
Conjunctival Neoplasms/*therapy
Adult ; Child ; Conjunctiva ; Humans ; Mitomycin ; Neoplasm Recurrence, Local
Czasopismo naukowe
Tytuł :
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
Autorzy :
Rivin Del Campo E; Department of Radiation Oncology, Tenon University Hospital, Sorbonne University, Paris, France. Electronic address: .
Matzinger O; Department of Radiation Oncology, Genolier Clinic, Genolier, Switzerland.
Haustermans K; Department of Radiation Oncology, UZ Leuven University Hospital, Leuven, Belgium.
Peiffert D; Department of Radiation Oncology, Institut de Cancérologie de Lorraine, Nancy, France.
Glynne-Jones R; Department of Radiation Oncology, Mount Vernon Cancer Centre, Northwood, United Kingdom.
Winter KA; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA.
Konski AA; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Leonard Davis Institute of Health Economics, West Chester, PA, USA; Department of Radiation Oncology, The Chester County Hospital, West Chester, PA, USA.
Ajani JA; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Bosset JF; Department of Radiation Oncology, Jean Minjoz University Hospital, Besançon, France.
Hannoun-Levi JM; Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France.
Puyraveau M; Department of Statistics, Jean Minjoz University Hospital, Besançon, France.
Chakravarthy AB; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Meadows H; Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom.
Northover J; Department of Surgery, The London Clinic and St Marks Hospital, London, United Kingdom.
Collette L; Department of Statistics, EORTC Headquarters, Brussels, Belgium.
Christiaens M; Department of Radiation Oncology, UZ Leuven University Hospital, Leuven, Belgium.
Maingon P; Department of Radiation Oncology, La Pitié Salpêtrière - Charles Foix University Hospital, Sorbonne University, Paris, France.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Nov; Vol. 121, pp. 130-143. Date of Electronic Publication: 2019 Sep 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Clinical Trials, Phase II as Topic*/methods
Clinical Trials, Phase II as Topic*/statistics & numerical data
Clinical Trials, Phase III as Topic*/methods
Clinical Trials, Phase III as Topic*/statistics & numerical data
Anus Neoplasms/*therapy
Chemoradiotherapy/*methods
Fluorouracil/*administration & dosage
Mitomycin/*administration & dosage
Anus Neoplasms/epidemiology ; Anus Neoplasms/pathology ; Chemoradiotherapy/adverse effects ; Combined Modality Therapy ; Fluorouracil/adverse effects ; Humans ; Mitomycin/adverse effects ; Neoplasm Recurrence, Local/ethnology ; Neoplasm Recurrence, Local/therapy ; Radiotherapy Dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant].
Autorzy :
Fili S; Klinik für Augenheilkunde, St.-Johannes-Hospital.
Seddig S; Klinik für Augenheilkunde, St.-Johannes-Hospital.
Kohlhaas M; Klinik für Augenheilkunde, St.-Johannes-Hospital.
Pokaż więcej
Transliterated Title :
Langzeitergebnisse nach Trabekulektomie kombiniert mit Mitomycin C und einem Ologen-Implantat.
Źródło :
Klinische Monatsblatter fur Augenheilkunde [Klin Monbl Augenheilkd] 2019 Sep; Vol. 236 (9), pp. 1107-1114. Date of Electronic Publication: 2018 Mar 28.
Typ publikacji :
Journal Article
MeSH Terms :
Collagen*/therapeutic use
Glaucoma*/therapy
Glycosaminoglycans*/therapeutic use
Mitomycin*/therapeutic use
Nucleic Acid Synthesis Inhibitors*/therapeutic use
Trabeculectomy*
Combined Modality Therapy ; Follow-Up Studies ; Humans ; Intraocular Pressure ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies